 Lung Diseases, Interstitial
"Lung Diseases, Interstitial" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
| Descriptor ID |
D017563
|
| MeSH Number(s) |
C08.381.483
|
| Concept/Terms |
Lung Diseases, Interstitial- Lung Diseases, Interstitial
- Interstitial Lung Disease
- Lung Disease, Interstitial
- Interstitial Lung Diseases
- Diffuse Parenchymal Lung Diseases
Pneumonia, Interstitial- Pneumonia, Interstitial
- Interstitial Pneumonia
- Interstitial Pneumonias
- Pneumonias, Interstitial
- Pneumonitis, Interstitial
- Interstitial Pneumonitides
- Interstitial Pneumonitis
- Pneumonitides, Interstitial
|
Below are MeSH descriptors whose meaning is more general than "Lung Diseases, Interstitial".
Below are MeSH descriptors whose meaning is more specific than "Lung Diseases, Interstitial".
This graph shows the total number of publications written about "Lung Diseases, Interstitial" by people in this website by year, and whether "Lung Diseases, Interstitial" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 | | 1996 | 2 | 0 | 2 | | 1998 | 1 | 2 | 3 | | 1999 | 1 | 1 | 2 | | 2000 | 1 | 0 | 1 | | 2001 | 1 | 0 | 1 | | 2002 | 4 | 0 | 4 | | 2003 | 3 | 2 | 5 | | 2004 | 4 | 2 | 6 | | 2005 | 5 | 2 | 7 | | 2006 | 8 | 2 | 10 | | 2007 | 10 | 0 | 10 | | 2008 | 5 | 0 | 5 | | 2009 | 12 | 1 | 13 | | 2010 | 9 | 1 | 10 | | 2011 | 6 | 1 | 7 | | 2012 | 12 | 2 | 14 | | 2013 | 19 | 0 | 19 | | 2014 | 12 | 1 | 13 | | 2015 | 11 | 3 | 14 | | 2016 | 14 | 2 | 16 | | 2017 | 17 | 1 | 18 | | 2018 | 13 | 0 | 13 | | 2019 | 20 | 0 | 20 | | 2020 | 16 | 0 | 16 | | 2021 | 19 | 1 | 20 | | 2022 | 24 | 1 | 25 | | 2023 | 25 | 0 | 25 | | 2024 | 11 | 2 | 13 |
To return to the timeline, click here.
Below are the most recent publications written about "Lung Diseases, Interstitial" by people in Profiles.
-
Kamiya M, Carter H, Espindola MS, Doyle TJ, Lee JS, Merriam LT, Zhang F, Kawano-Dourado L, Sparks JA, Hogaboam CM, Moore BB, Oldham WM, Kim EY. Immune mechanisms in fibrotic interstitial lung disease. Cell. 2024 Jul 11; 187(14):3506-3530.
-
Poole JA, England BR, Sayles H, Johnson TM, Duryee MJ, Hunter CD, Baker JF, Kerr GS, Kunkel G, Cannon GW, Sauer BC, Wysham KD, Joseph AM, Wallace BI, Thiele GM, Mikuls TR. Serum alarmins and the risk of incident interstitial lung disease in rheumatoid arthritis. Rheumatology (Oxford). 2024 Jul 01; 63(7):1998-2005.
-
Humphries SM, Thieke D, Baraghoshi D, Strand MJ, Swigris JJ, Chae KJ, Hwang HJ, Oh AS, Flaherty KR, Adegunsoye A, Jablonski R, Lee CT, Husain AN, Chung JH, Strek ME, Lynch DA. Deep Learning Classification of Usual Interstitial Pneumonia Predicts Outcomes. Am J Respir Crit Care Med. 2024 05 01; 209(9):1121-1131.
-
Herman D, Ghazipura M, Barnes H, Macrea M, Knight SL, Silver RM, Montesi SB, Raghu G, Hossain T. Nintedanib Therapy Alone and Combined with Mycophenolate in Patients with Systemic Sclerosis-associated Interstitial Lung Disease: Systematic Reviews and Meta-analysis. Ann Am Thorac Soc. 2024 Mar; 21(3):474-485.
-
Oh AS, Lynch DA, Swigris JJ, Baraghoshi D, Dyer DS, Hale VA, Koelsch TL, Marrocchio C, Parker KN, Teague SD, Flaherty KR, Humphries SM. Deep Learning-based Fibrosis Extent on Computed Tomography Predicts Outcome of Fibrosing Interstitial Lung Disease Independent of Visually Assessed Computed Tomography Pattern. Ann Am Thorac Soc. 2024 Feb; 21(2):218-227.
-
Macrea M, Ghazipura M, Herman D, Barnes H, Knight SL, Silver RM, Montesi SB, Raghu G, Hossain T. Rituximab in Patients with Systemic Sclerosis-associated Interstitial Lung Disease: A Systematic Review and Meta-Analysis. Ann Am Thorac Soc. 2024 Feb; 21(2):317-327.
-
Ghazipura M, Macrea M, Herman D, Barnes H, Knight SL, Silver RM, Montesi SB, Raghu G, Hossain T. Tocilizumab in Patients with Systemic Sclerosis-associated Interstitial Lung Disease: A Systematic Review and Meta-Analysis. Ann Am Thorac Soc. 2024 Feb; 21(2):328-337.
-
Doyle TJ, Juge PA, Peljto AL, Lee S, Walts AD, Esposito AJ, Poli S, Gill R, Hatabu H, Nishino M, Dellaripa PF, Weinblatt ME, Shadick NA, Demoruelle MK, Sparks JA, Rosas IO, Granger B, Deane KD, Crestani B, Wolters PJ, Dieud? P, Lee JS. Short peripheral blood leukocyte telomere length in rheumatoid arthritis-interstitial lung disease. Thorax. 2024 01 18; 79(2):182-185.
-
Bekelman DB, Feser W, Morgan B, Welsh CH, Parsons EC, Paden G, Baron A, Hattler B, McBryde C, Cheng A, Lange AV, Au DH. Nurse and Social Worker Palliative Telecare Team and Quality of Life in Patients With COPD, Heart Failure, or Interstitial Lung Disease: The ADAPT Randomized Clinical Trial. JAMA. 2024 01 16; 331(3):212-223.
-
Raghu G, Montesi SB, Silver RM, Hossain T, Macrea M, Herman D, Barnes H, Adegunsoye A, Azuma A, Chung L, Gardner GC, Highland KB, Hudson M, Kaner RJ, Kolb M, Scholand MB, Steen V, Thomson CC, Volkmann ER, Wigley FM, Burlile D, Kemper KA, Knight SL, Ghazipura M. Treatment of Systemic Sclerosis-associated Interstitial Lung Disease: Evidence-based Recommendations. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2024 01 15; 209(2):137-152.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|